Related content

Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

By Fu H.   Muenzer J.   Samulski R.J.   Breese G.   Sifford J.   Zeng X.   McCarty D.M.  

Molecular Therapy, Vol. 8, Iss. 6, 2003-12 ,pp. : 911-917 (7)

Elsevier

Access to resources Recommend Favorite

Gene Therapy for Pyruvate Dehydrogenase E1 Deficiency Using Recombinant Adeno-Associated Virus 2 (rAAV2) Vectors

By Owen R.   Mandel R.J.   Ammini C.V.   Conlon T.J.   Kerr D.S.   Stacpoole P.W.   Flotte T.R.  

Molecular Therapy, Vol. 6, Iss. 3, 2002-09 ,pp. : 394-399 (6)

Elsevier

Access to resources Recommend Favorite

Intramuscular Administration of Recombinant Adeno-Associated Virus 2 -1 Antitrypsin (rAAV-SERPINA1) Vectors in a Nonhuman Primate Model: Safety and Immunologic Aspects

By Song S.   Scott-Jorgensen M.   Wang J.   Poirier A.   Crawford J.   Campbell-Thompson M.   Flotte T.R.  

Molecular Therapy, Vol. 6, Iss. 3, 2002-09 ,pp. : 329-335 (7)

Elsevier

Access to resources Recommend Favorite

Adeno-associated virus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor reduces atherosclerotic lesion formation in LDL receptor knockout mice

By Jalkanen J.   Leppanen P.   Pajusola K.   Narvanen O.   Mahonen A.   Vahakangas E.   Greaves D.R.   Bueler H.   Yla-Herttuala S.  

Molecular Therapy, Vol. 8, Iss. 6, 2003-12 ,pp. : 903-910 (8)

Elsevier

Access to resources Recommend Favorite

Pharmacological Chaperones in Nephrogenic Diabetes Insipidus: Possibilities for Clinical Application

By Robben Joris H.  

BioDrugs, Vol. 21, Iss. 3, 2007-01 ,pp. : 157-166 (10)

Adis International

Access to resources Recommend Favorite